NatureWise Biotech & Medicals Balance Sheet Health
Financial Health criteria checks 6/6
NatureWise Biotech & Medicals has a total shareholder equity of NT$641.9M and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$700.9M and NT$59.0M respectively. NatureWise Biotech & Medicals's EBIT is NT$8.0M making its interest coverage ratio -1.3. It has cash and short-term investments of NT$493.9M.
Key information
0%
Debt to equity ratio
NT$0
Debt
| Interest coverage ratio | -1.3x |
| Cash | NT$493.91m |
| Equity | NT$641.93m |
| Total liabilities | NT$58.98m |
| Total assets | NT$700.91m |
Recent financial health updates
No updates
Recent updates
Lacklustre Performance Is Driving NatureWise Biotech & Medicals Corporation's (GTSM:4732) Low P/E
Apr 29
A Look At The Intrinsic Value Of NatureWise Biotech & Medicals Corporation (GTSM:4732)
Mar 25Here's Why We Don't Think NatureWise Biotech & Medicals's (GTSM:4732) Statutory Earnings Reflect Its Underlying Earnings Potential
Dec 20
Financial Position Analysis
Short Term Liabilities: 4732's short term assets (NT$630.2M) exceed its short term liabilities (NT$50.6M).
Long Term Liabilities: 4732's short term assets (NT$630.2M) exceed its long term liabilities (NT$8.4M).
Debt to Equity History and Analysis
Debt Level: 4732 is debt free.
Reducing Debt: 4732 has not had any debt for past 5 years.
Debt Coverage: 4732 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 4732 has no debt, therefore coverage of interest payments is not a concern.